Relapsed or refractory T-cell malignancies (T-ALL or T-LBL) research hub

CAR T cells for T cell cancers

This study checks a new cell treatment called CAR T-cells for aggressive T-cell cancers that haven't responded to usual treatments. We take your own immune cells, teach them to find and kill cancer, and give them back. It aims to see if this treatment is safe and what the best dose is.